Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Six Months Versus 12 Months of Oral Itraconazole Therapy for Chronic Pulmonary Aspergillosis
NCT03920527Phase 3Completed
- Sponsor
- Post Graduate Institute of Medical Education and Research
- Start
- Jul 2019
- Primary completion
- Jul 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of itraconazole in chronic pulmonary aspergillosis (CPA), sponsored by Post Graduate Institute of Medical Education and Research. Started Jul 2019; status: completed.
02
Drugs
itraconazole
03
Conditions
chronic pulmonary aspergillosis (CPA)
Beyond the preview
Go deeper on NCT03920527.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03920527.